Report on remission in patients with MS three years after stem cell transplant

Three years after a small number of patients with multiple sclerosis were treated with high-dose immunosuppressive therapy and then transplanted with their own hematopoietic stem cells, most of the patients sustained remission of active relapsing-remitting MS and had improvements in neurological function, according to a study. Three years after a small number of patients with multiple sclerosis were treated with high-dose immunosuppressive therapy and then transplanted with their own hematopoietic stem cells, most of the patients sustained remission of active relapsing-remitting MS and had improvements in neurological function, according to a study published online by JAMA Neurology .

http://www.sciencedaily.com/releases/2014/12/141229164854.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily%2Fmind_brain%2Fdisorders_and_syndromes+%28Disorders+and+Syndromes+News+--+ScienceDaily%29